Cargando…

Nanoclays: Promising Materials for Vaccinology

Clay materials and nanoclays have gained recent popularity in the vaccinology field, with biocompatibility, simple functionalization, low toxicity, and low-cost as their main attributes. As elements of nanovaccines, halloysite nanotubes (natural), layered double hydroxides and hectorite (synthetic)...

Descripción completa

Detalles Bibliográficos
Autores principales: Govea-Alonso, Dania O., García-Soto, Mariano J., Betancourt-Mendiola, Lourdes, Padilla-Ortega, Erika, Rosales-Mendoza, Sergio, González-Ortega, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505858/
https://www.ncbi.nlm.nih.gov/pubmed/36146630
http://dx.doi.org/10.3390/vaccines10091549
_version_ 1784796578227159040
author Govea-Alonso, Dania O.
García-Soto, Mariano J.
Betancourt-Mendiola, Lourdes
Padilla-Ortega, Erika
Rosales-Mendoza, Sergio
González-Ortega, Omar
author_facet Govea-Alonso, Dania O.
García-Soto, Mariano J.
Betancourt-Mendiola, Lourdes
Padilla-Ortega, Erika
Rosales-Mendoza, Sergio
González-Ortega, Omar
author_sort Govea-Alonso, Dania O.
collection PubMed
description Clay materials and nanoclays have gained recent popularity in the vaccinology field, with biocompatibility, simple functionalization, low toxicity, and low-cost as their main attributes. As elements of nanovaccines, halloysite nanotubes (natural), layered double hydroxides and hectorite (synthetic) are the nanoclays that have advanced into the vaccinology field. Until now, only physisorption has been used to modify the surface of nanoclays with antigens, adjuvants, and/or ligands to create nanovaccines. Protocols to covalently attach these molecules have not been developed with nanoclays, only procedures to develop adsorbents based on nanoclays that could be extended to develop nanovaccine conjugates. In this review, we describe the approaches evaluated on different nanovaccine candidates reported in articles, the immunological results obtained with them and the most advanced approaches in the preclinical field, while describing the nanomaterial itself. In addition, complex systems that use nanoclays were included and described. The safety of nanoclays as carriers is an important key fact to determine their true potential as nanovaccine candidates in humans. Here, we present the evaluations reported in this field. Finally, we point out the perspectives in the development of vaccine prototypes using nanoclays as antigen carriers.
format Online
Article
Text
id pubmed-9505858
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95058582022-09-24 Nanoclays: Promising Materials for Vaccinology Govea-Alonso, Dania O. García-Soto, Mariano J. Betancourt-Mendiola, Lourdes Padilla-Ortega, Erika Rosales-Mendoza, Sergio González-Ortega, Omar Vaccines (Basel) Review Clay materials and nanoclays have gained recent popularity in the vaccinology field, with biocompatibility, simple functionalization, low toxicity, and low-cost as their main attributes. As elements of nanovaccines, halloysite nanotubes (natural), layered double hydroxides and hectorite (synthetic) are the nanoclays that have advanced into the vaccinology field. Until now, only physisorption has been used to modify the surface of nanoclays with antigens, adjuvants, and/or ligands to create nanovaccines. Protocols to covalently attach these molecules have not been developed with nanoclays, only procedures to develop adsorbents based on nanoclays that could be extended to develop nanovaccine conjugates. In this review, we describe the approaches evaluated on different nanovaccine candidates reported in articles, the immunological results obtained with them and the most advanced approaches in the preclinical field, while describing the nanomaterial itself. In addition, complex systems that use nanoclays were included and described. The safety of nanoclays as carriers is an important key fact to determine their true potential as nanovaccine candidates in humans. Here, we present the evaluations reported in this field. Finally, we point out the perspectives in the development of vaccine prototypes using nanoclays as antigen carriers. MDPI 2022-09-17 /pmc/articles/PMC9505858/ /pubmed/36146630 http://dx.doi.org/10.3390/vaccines10091549 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Govea-Alonso, Dania O.
García-Soto, Mariano J.
Betancourt-Mendiola, Lourdes
Padilla-Ortega, Erika
Rosales-Mendoza, Sergio
González-Ortega, Omar
Nanoclays: Promising Materials for Vaccinology
title Nanoclays: Promising Materials for Vaccinology
title_full Nanoclays: Promising Materials for Vaccinology
title_fullStr Nanoclays: Promising Materials for Vaccinology
title_full_unstemmed Nanoclays: Promising Materials for Vaccinology
title_short Nanoclays: Promising Materials for Vaccinology
title_sort nanoclays: promising materials for vaccinology
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505858/
https://www.ncbi.nlm.nih.gov/pubmed/36146630
http://dx.doi.org/10.3390/vaccines10091549
work_keys_str_mv AT goveaalonsodaniao nanoclayspromisingmaterialsforvaccinology
AT garciasotomarianoj nanoclayspromisingmaterialsforvaccinology
AT betancourtmendiolalourdes nanoclayspromisingmaterialsforvaccinology
AT padillaortegaerika nanoclayspromisingmaterialsforvaccinology
AT rosalesmendozasergio nanoclayspromisingmaterialsforvaccinology
AT gonzalezortegaomar nanoclayspromisingmaterialsforvaccinology